Description
British Dispensary Flux Retatrutide + MOTS-C + AOD is a premium multi-peptide research formulation combining Retatrutide, MOTS-C, and AOD-9604 (AOD) into a single advanced investigational blend. Developed exclusively for laboratory research, this innovative peptide combination is extensively investigated for its role in metabolic physiology, mitochondrial biology, energy homeostasis, peptide signaling, and molecular endocrinology through complementary biological mechanisms.
By combining a triple incretin receptor agonist, a mitochondrial-derived peptide, and a Human Growth Hormone fragment, Flux Retatrutide + MOTS-C + AOD provides researchers with a comprehensive platform for studying glucose metabolism, mitochondrial signaling, cellular energy regulation, lipid metabolism, endocrine communication, and peptide pharmacology.
Each package contains 5 sterile vials, with Retatrutide 6 mg, MOTS-C 15 mg, and AOD-9604 (AOD) 6 mg per vial, providing a total peptide concentration of 27 mg per vial. Manufactured by British Dispensary under stringent pharmaceutical-quality standards, every batch undergoes comprehensive quality testing to ensure exceptional purity, peptide integrity, and dependable laboratory performance.
Key Features
- Premium multi-peptide research formulation
- 5 sterile vials per package
- Retatrutide – 6 mg per vial
- MOTS-C – 15 mg per vial
- AOD-9604 (HGH Fragment) – 6 mg per vial
- Total peptide concentration: 27 mg per vial
- Combines a triple receptor agonist, mitochondrial-derived peptide, and HGH fragment
- High-purity laboratory-grade peptide formulation
- Suitable for investigations involving metabolic physiology, mitochondrial biology, glucose metabolism, lipid metabolism, peptide pharmacology, cellular signaling, energy homeostasis, and molecular endocrinology
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
Flux Retatrutide + MOTS-C + AOD combines three investigational peptides with complementary biological mechanisms, allowing researchers to investigate multiple metabolic pathways within a single laboratory model.
- Retatrutide – 6 mg is a triple receptor agonist that activates the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and Glucagon receptor (GCGR). Researchers investigate its role in metabolic signaling, glucose regulation, receptor pharmacology, and endocrine communication.
- MOTS-C – 15 mg is a naturally occurring mitochondrial-derived peptide (MDP) extensively researched for its involvement in mitochondrial function, cellular energy metabolism, metabolic signaling, AMPK activation, and cellular stress responses.
- AOD-9604 – 6 mg is a synthetic peptide corresponding to amino acids 176–191 of Human Growth Hormone and is investigated for its role in lipid metabolism, adipocyte biology, metabolic regulation, and peptide-mediated cellular signaling.
Together, these complementary peptides provide researchers with a comprehensive platform for investigating multi-receptor signaling, mitochondrial physiology, glucose metabolism, lipid metabolism, cellular communication, energy homeostasis, peptide pharmacology, and molecular endocrinology.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredients (Per Vial):
- Retatrutide – 6 mg
- MOTS-C – 15 mg
- AOD-9604 (HGH Fragment 176-191) – 6 mg
Total Peptide Concentration: 27 mg per Vial
Packaging:
- 5 Sterile Vials
Reviews
There are no reviews yet.